[HTML][HTML] Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100

MM Véniant, MA Sullivan, SK Kim… - The Journal of …, 2000 - Am Soc Clin Investig
MM Véniant, MA Sullivan, SK Kim, P Ambroziak, A Chu, MD Wilson, MK Hellerstein
The Journal of clinical investigation, 2000Am Soc Clin Investig
Apo-E–deficient apo-B100–only mice (Apoe–/–Apob 100/100) and LDL receptor–deficient
apo-B100–only mice (Ldlr–/–Apob 100/100) have similar total plasma cholesterol levels, but
nearly all of the plasma cholesterol in the former animals is packaged in VLDL particles,
whereas, in the latter, plasma cholesterol is found in smaller LDL particles. We compared
the apo-B100–containing lipoprotein populations in these mice to determine their relation to
susceptibility to atherosclerosis. The median size of the apo-B100–containing lipoprotein …
Apo-E–deficient apo-B100–only mice (Apoe–/–Apob100/100) and LDL receptor–deficient apo-B100–only mice (Ldlr–/–Apob100/100) have similar total plasma cholesterol levels, but nearly all of the plasma cholesterol in the former animals is packaged in VLDL particles, whereas, in the latter, plasma cholesterol is found in smaller LDL particles. We compared the apo-B100–containing lipoprotein populations in these mice to determine their relation to susceptibility to atherosclerosis. The median size of the apo-B100–containing lipoprotein particles in Apoe–/–Apob100/100 plasma was 53.4 nm versus only 22.1 nm in Ldlr–/–Apob100/100 plasma. The plasma levels of apo-B100 were three- to fourfold higher in Ldlr–/–Apob100/100 mice than in Apoe–/–Apob100/100 mice. After 40 weeks on a chow diet, the Ldlr–/–Apob100/100 mice had more extensive atherosclerotic lesions than Apoe–/–Apob100/100 mice. The aortic DNA synthesis rate and the aortic free and esterified cholesterol contents were also higher in the Ldlr–/–Apob100/100 mice. These findings challenge the notion that all non-HDL lipoproteins are equally atherogenic and suggest that at a given cholesterol level, large numbers of small apo-B100–containing lipoproteins are more atherogenic than lower numbers of large apo-B100–containing lipoproteins.
The Journal of Clinical Investigation